Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
暂无分享,去创建一个
M. Baggiolini | S. Kunkel | A. Walz | M Baggiolini | S L Kunkel | A Walz | Marco Baggiolini | Alfred Walz | Steven L. Kunkel
[1] B. Dewald,et al. The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils , 1989, The Journal of experimental medicine.
[2] J. Besemer,et al. Specific binding, internalization, and degradation of human neutrophil activating factor by human polymorphonuclear leukocytes. , 1989, The Journal of biological chemistry.
[3] B. Dewald,et al. Histamine and sulfidoleukotriene release from human basophils: different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil-activating peptide NAF. , 1989, International archives of allergy and applied immunology.
[4] R. Strieter,et al. Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. , 1989, The Journal of biological chemistry.
[5] J. Westwick,et al. Novel neutrophil-stimulating peptides. , 1989, Immunology today.
[6] B. Dewald,et al. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. , 1989, The American journal of pathology.
[7] M. Baggiolini,et al. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils. , 1989, Biochemical and biophysical research communications.
[8] E. Appella,et al. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.
[9] R. Strieter,et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. , 1989, Science.
[10] J. Shabanowitz,et al. Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Matsushima,et al. Brief Definitive Report Identification and Characterization of Specific Receptors for Monocyte-derived Neutrophil Chemotactic Factor (mdncf) on Human Neutrophils , 2022 .
[12] M. Yamada,et al. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). , 1989, Biochemical and biophysical research communications.
[13] T. Mosmann,et al. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. , 1989, Journal of immunology.
[14] J. Schröder,et al. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. , 1989, Journal of immunology.
[15] E. Appella,et al. Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. , 1989, Molecular immunology.
[16] A. Cerami,et al. Identification and characterization of macrophage inflammatory protein 2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Dewald,et al. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Strieter,et al. Monokine-induced gene expression of a human endothelial cell-derived neutrophil chemotactic factor. , 1988, Biochemical and biophysical research communications.
[19] B. Dewald,et al. Two transduction sequences are necessary for neutrophil activation by receptor agonists. , 1988, The Journal of biological chemistry.
[20] J. Westwick,et al. Elevation of PMN cytosolic free calcium and locomotion stimulated by novel peptides from IL-1-treated human synovial cell cultures. , 1988, Biochemical and biophysical research communications.
[21] M. Baggiolini,et al. Mechanism of neutrophil activation by NAF, a novel monocyte‐derived peptide agonist , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] R. Derynck,et al. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin. , 1988, The EMBO journal.
[23] E. Appella,et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.
[24] B. Dewald,et al. A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.
[25] T. Martin,et al. A peptide from alveolar macrophages that releases neutrophil enzymes into the lungs in patients with the adult respiratory distress syndrome. , 1988, The American review of respiratory disease.
[26] D. Remick,et al. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. , 1988, The Journal of biological chemistry.
[27] J. van Beeumen,et al. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity , 1988, The Journal of experimental medicine.
[28] J. Schröder,et al. Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). , 1988, Biochemical and biophysical research communications.
[29] L. Moldawer,et al. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties , 1988, The Journal of experimental medicine.
[30] B. Dewald,et al. Effects of PAF on neutrophils and mononuclear phagocytes. , 1988, Progress in biochemical pharmacology.
[31] M. Baggiolini,et al. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. , 1987, Biochemical and biophysical research communications.
[32] E. Appella,et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Schröder,et al. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. , 1987, Journal of immunology.
[34] L. Bardwell,et al. Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[35] K. Matsushima,et al. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.
[36] C. Weissmann,et al. Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes. , 1987, Journal of immunology.
[37] A. Tauber. Protein kinase C and the activation of the human neutrophil NADPH-oxidase. , 1987, Blood.
[38] J. Schröder,et al. Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. , 1986, The Journal of investigative dermatology.
[39] H. Ochs,et al. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. , 1986, Journal of immunology.
[40] A. Henschen,et al. Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin. , 1986, Biochemistry.
[41] R. Snyderman,et al. Receptor-coupled activation of phosphoinositide-specific phospholipase C by an N protein. , 1986, Science.
[42] R. Colman,et al. Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. , 1985, The American review of respiratory disease.
[43] R. Cotran,et al. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.
[44] P. Parsons,et al. Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome. , 1985, The American review of respiratory disease.
[45] Andrew D. Luster,et al. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.
[46] T. Hugli,et al. Structure and function of the anaphylatoxins , 1985 .
[47] Michael J. Berridge,et al. Inositol trisphosphate, a novel second messenger in cellular signal transduction , 1984, Nature.
[48] T. Hugli. Structure and function of the anaphylatoxins. , 1984, Springer seminars in immunopathology.
[49] C B Wollheim,et al. Is cytosolic ionized calcium regulating neutrophil activation? , 1983, Science.
[50] M. Schork,et al. Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.
[51] J. W. Miller,et al. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Lefkowitz,et al. The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. , 1982, Biochemical and biophysical research communications.
[53] R. Spragg,et al. Studies on the pathogenesis of the adult respiratory distress syndrome. , 1982, The Journal of clinical investigation.
[54] R. Crystal,et al. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. , 1981, The Journal of clinical investigation.
[55] M. A. Bray,et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.
[56] B. Dewald,et al. Cellular mechanisms of proteinase release from inflammatory cells and the degradation of extracellular proteins. , 1979, Ciba Foundation symposium.
[57] D. Pepper,et al. Complete covalent structure of human beta-thromboglobulin. , 1978, Biochemistry.
[58] P. Henson,et al. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. , 1978, Journal of immunology.
[59] R. Heinrikson,et al. Amino acid sequence of human platelet factor 4. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[60] R. Lefkowitz,et al. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[61] S. Wahl,et al. N-formylmethionyl peptides as chemoattractants for leucocytes. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[62] A. Cederberg,et al. STUDIES ON THE ELIMINATION OF GRANULOCYTES IN THE INTESTINAL TRACT IN RAT. , 2009, Acta pathologica et microbiologica Scandinavica.